Dashboard
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- Poor long term growth as Operating profit has grown by an annual rate 9.33% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
With a growth in Net Sales of 16.85%, the company declared Very Positive results in Apr 25
3
Risky - Negative EBITDA
4
Market Beating Performance
Stock DNA
Pharmaceuticals & Biotechnology
JPY 23,792 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.61
-113.07%
10.74
Revenue and Profits:
Net Sales:
1,875 Million
(Quarterly Results - Apr 2025)
Net Profit:
-1,107 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
47.22%
0%
47.22%
6 Months
102.55%
0%
102.55%
1 Year
186.49%
0%
186.49%
2 Years
90.42%
0%
90.42%
3 Years
3.25%
0%
3.25%
4 Years
-1.55%
0%
-1.55%
5 Years
-2.15%
0%
-2.15%
3-D Matrix Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
59.69%
EBIT Growth (5y)
9.33%
EBIT to Interest (avg)
-242.52
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.46
Sales to Capital Employed (avg)
0.84
Tax Ratio
0.89%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.96
EV to EBIT
-15.36
EV to EBITDA
-15.36
EV to Capital Employed
4.40
EV to Sales
2.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-28.64%
ROE (Latest)
-37.31%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Apr'25 - YoY
Apr'25
Apr'24
Change(%)
Net Sales
1,874.70
1,604.40
16.85%
Operating Profit (PBDIT) excl Other Income
-550.20
-498.70
-10.33%
Interest
14.80
21.00
-29.52%
Exceptional Items
6.50
44.80
-85.49%
Consolidate Net Profit
-1,107.40
444.40
-349.19%
Operating Profit Margin (Excl OI)
-293.50%
-310.90%
1.74%
USD in Million.
Net Sales
YoY Growth in quarter ended Apr 2025 is 16.85% vs 112.33% in Apr 2024
Consolidated Net Profit
YoY Growth in quarter ended Apr 2025 is -349.19% vs 222.32% in Apr 2024
Annual Results Snapshot (Consolidated) - Apr'25
Apr'25
Apr'24
Change(%)
Net Sales
6,934.10
4,588.80
51.11%
Operating Profit (PBDIT) excl Other Income
-1,156.20
-2,117.00
45.38%
Interest
74.40
83.80
-11.22%
Exceptional Items
4.60
-164.80
102.79%
Consolidate Net Profit
-2,501.20
-255.50
-878.94%
Operating Profit Margin (Excl OI)
-166.70%
-461.30%
29.46%
USD in Million.
Net Sales
YoY Growth in year ended Apr 2025 is 51.11% vs 98.30% in Apr 2024
Consolidated Net Profit
YoY Growth in year ended Apr 2025 is -878.94% vs 89.55% in Apr 2024
About 3-D Matrix Ltd. 
3-D Matrix Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






